Fetal Monitors - Medical Devices Pipeline Assessment, 2017

Published : Jul-2017

No. of Pages : 90

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Fetal Monitors Overview 7
3 Products under Development 8
3.1 Fetal Monitors - Pipeline Products by Stage of Development 8
3.2 Fetal Monitors - Pipeline Products by Segment 9
3.3 Fetal Monitors - Pipeline Products by Territory 10
3.4 Fetal Monitors - Pipeline Products by Regulatory Path 11
3.5 Fetal Monitors - Pipeline Products by Estimated Approval Date 12
3.6 Fetal Monitors - Ongoing Clinical Trials 13
4 Fetal Monitors - Pipeline Products under Development by Companies 14
4.1 Fetal Monitors Companies - Pipeline Products by Stage of Development 14
4.2 Fetal Monitors - Pipeline Products by Stage of Development 15
5 Fetal Monitors Companies and Product Overview 16
5.1 ARVUS Trading and Service Ltd. Company Overview 16
5.1.1 ARVUS Trading and Service Ltd. Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 BCB Informatica Y Control SL Company Overview 17
5.2.1 BCB Informatica Y Control SL Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Biotricity Medical Inc. Company Overview 18
5.3.1 Biotricity Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Brun Health Pvt Ltd Company Overview 19
5.4.1 Brun Health Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 Convergent Engineering, Inc. Company Overview 20
5.5.1 Convergent Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 Farus, LLC Company Overview 21
5.6.1 Farus, LLC Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 First Pulse Medical, Inc. Company Overview 22
5.7.1 First Pulse Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 LifeWave Hi-Tech Medical Devices Ltd. Company Overview 23
5.8.1 LifeWave Hi-Tech Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
5.9 Lono Medical Systems, LLC. Company Overview 25
5.9.1 Lono Medical Systems, LLC. Pipeline Products & Ongoing Clinical Trials Overview 25
5.10 MBDevice, LLC Company Overview 26
5.10.1 MBDevice, LLC Pipeline Products & Ongoing Clinical Trials Overview 26
5.11 MindChild Medical Inc. Company Overview 27
5.11.1 MindChild Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.12 Monica Healthcare Ltd Company Overview 32
5.12.1 Monica Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 Neoventa Medical AB Company Overview 33
5.13.1 Neoventa Medical AB Pipeline Products & Ongoing Clinical Trials Overview 33
5.14 Perinatronics Medical systems Inc Company Overview 34
5.14.1 Perinatronics Medical systems Inc Pipeline Products & Ongoing Clinical Trials Overview 34
5.15 Sattva MedTech Company Overview 35
5.15.1 Sattva MedTech Pipeline Products & Ongoing Clinical Trials Overview 35
5.16 Tiny Kicks LLC Company Overview 36
5.16.1 Tiny Kicks LLC Pipeline Products & Ongoing Clinical Trials Overview 36
5.17 Tristan Technologies Inc Company Overview 37
5.17.1 Tristan Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 37
5.18 Two Dimensional Instruments, LLC Company Overview 39
5.18.1 Two Dimensional Instruments, LLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.19 University of California San Diego Company Overview 40
5.19.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 40
6 Fetal Monitors- Recent Developments 41
6.1 Jun 06, 2017: Analogic Announces Results for the Third Quarter Ended April 30, 2017 and Declares Quarterly Cash Dividend 41
6.2 May 18, 2017: McKesson Reports Fiscal 2017 Fourth-Quarter and Full-Year Results 43
6.3 Apr 27, 2017: Cerner Reports First Quarter 2017 Results 46
6.4 Apr 25, 2017: Getinge: Interim Report January-March 2017 46
6.5 Apr 20, 2017: Chief Financial Officer leaves Getinge 47
6.6 Apr 10, 2017: MindChild Medical Announces Publication of "Evaluation of the fetal QT interval using non-invasive fetal ECG technology" With the MERIDIAN Fetal Monitoring System 47
6.7 Mar 29, 2017: Resolutions at Getinge's Annual General Meeting 2017 49
6.8 Mar 21, 2017: The new Getinge logo - inspired by the star of life 50
6.9 Mar 20, 2017: Getinge establishes new brand structure and becomes a single brand company 50
6.10 Mar 15, 2017: Getinge to exhibit full product portfolio for Intensive Care Units at International Symposium on Intensive Care and Emergency Medicine (ISICEM) 50
6.11 Mar 06, 2017: Cerner Announces Appointment of Julie Gerberding to Its Board of Directors 51
6.12 Mar 06, 2017: Analogic Announces Results for the Second Quarter ended January 31, 2017 and Declares Quarterly Cash Dividend 51
6.13 Mar 02, 2017: McKesson Provides Financial Update to Reflect Creation of a New Healthcare Information Technology Company 54
6.14 Feb 09, 2017: Cerner Reports Fourth Quarter and Full Year 2016 Results 55
6.15 Jan 26, 2017: Getinge Year-End Report January-December 2016 56
6.16 Jan 26, 2017: Vantage Oncology's 50 Centers and More Than 350 Affiliated Physicians Join The US Oncology Network 57
6.17 Jan 25, 2017: McKesson Reports Fiscal 2017 Third-Quarter Results 58
6.18 Jan 17, 2017: MindChild Medical Announces Clearance of a 510(k) Pre-Marketing Notification with the US Food and Drug Administration for the MERIDIAN M110 Fetal Monitoring System 61
6.19 Jan 17, 2017: McKesson Finalizes Settlement with U.S. Department of Justice and U.S. Drug Enforcement Administration to Resolve Past Claims 62
6.20 Jan 15, 2017: Getinge Group to exhibit complete product portfolio at Arab Health 63
6.21 Jan 05, 2017: McKesson and Change Healthcare Announce New Company Will Be Named Change Healthcare 64
6.22 Dec 28, 2016: McKesson Completes Acquisition of Rexall Health and Appoints Domenic Pilla as CEO of McKesson Canada 65
6.23 Dec 21, 2016: McKesson and Change Healthcare Announce Termination off Hart-Scott-Rodino Act Waiting Period for the Creation of a New Healthcare Information Technology Company 66
6.24 Dec 06, 2016: Analogic Announces Results for the First Quarter ended October 31, 2016 and Declares Quarterly Cash Dividend 66
6.25 Nov 03, 2016: Mattias Perjos appointed President and CEO of Getinge Group 67
6.26 Nov 01, 2016: Cerner Reports Third Quarter 2016 Results 68
6.27 Oct 27, 2016: McKesson Reports Fiscal 2017 Second-Quarter Results and Revised Fiscal 2017 Outlook 69
6.28 Oct 24, 2016: McKesson Releases Fiscal 2016 Corporate Social Responsibility Report 71
6.29 Oct 24, 2016: Analogic Announces Leadership Transition 72
6.30 Oct 18, 2016: Further developed and focused strategy, and preparation for distribution of Patient & Post-Acute Care to shareholders of Getinge 73
6.31 Oct 18, 2016: Getinge Interim Report January-September 2016 74
6.32 Oct 04, 2016: Bionet America Introduces New and Improved FC 1400 (Twin Fetus Fetal Monitor) 77
6.33 Sep 21, 2016: Analogic Announces Results for the Fourth Quarter and Fiscal Year Ended July 31, 2016 and Declares Quarterly Cash Dividend 77
6.34 Aug 22, 2016: Replacement of President & CEO Getinge Group:Joacim Lindoff appointed Acting President & CEO of Getinge Group 78
6.35 Aug 22, 2016: Joacim Lindoff appointed Acting President & CEO of Getinge Group 79
6.36 Aug 02, 2016: Cerner Reports Second Quarter 2016 Results 79
6.37 Jul 27, 2016: McKesson Reports Fiscal 2017 First-Quarter Results 80
6.38 Jul 14, 2016: Getinge Interim Report January-June 2016 82
6.39 Jun 29, 2016: McKesson Updates Fiscal 2017 Guidance 82
6.40 Jun 28, 2016: McKesson and Change Healthcare to Form New Healthcare Information Technology Company 83
6.41 Jun 27, 2016: McKesson Shares Ideas with Independent Pharmacies to Deliver Better Patient Outcomes and Grow Their Businesses 84
7 Appendix 87
7.1 Methodology 87
7.2 About GlobalData 90
7.3 Contact Us 90
7.4 Disclaimer 90

1.1 List of Tables
Table 1: Fetal Monitors - Pipeline Products by Stage of Development 8
Table 2: Fetal Monitors - Pipeline Products by Segment 9
Table 3: Fetal Monitors - Pipeline Products by Territory 10
Table 4: Fetal Monitors - Pipeline Products by Regulatory Path 11
Table 5: Fetal Monitors - Pipeline Products by Estimated Approval Date 12
Table 6: Fetal Monitors - Ongoing Clinical Trials 13
Table 7: Fetal Monitors Companies - Pipeline Products by Stage of Development 14
Table 8: Fetal Monitors - Pipeline Products by Stage of Development 15
Table 9: ARVUS Trading and Service Ltd. Pipeline Products & Ongoing Clinical Trials Overview 16
Table 10: Wireless Fetal Pulse Oximeter - Product Status 16
Table 11: Wireless Fetal Pulse Oximeter - Product Description 16
Table 12: BCB Informatica Y Control SL Pipeline Products & Ongoing Clinical Trials Overview 17
Table 13: Baby Beat - Product Status 17
Table 14: Baby Beat - Product Description 17
Table 15: Biotricity Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
Table 16: Fetal Monitoring Device - Product Status 18
Table 17: Fetal Monitoring Device - Product Description 18
Table 18: Brun Health Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
Table 19: Brün - Product Status 19
Table 20: Brün - Product Description 19
Table 21: Convergent Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 22: eToco +fHR (fetal heart rate) Device - Product Status 20
Table 23: eToco +fHR (fetal heart rate) Device - Product Description 20
Table 24: Farus, LLC Pipeline Products & Ongoing Clinical Trials Overview 21
Table 25: Portable External Fetal Heart Monitor - Product Status 21
Table 26: Portable External Fetal Heart Monitor - Product Description 21
Table 27: First Pulse Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 28: Trans-reflective Fetal EKG Monitor - Product Status 22
Table 29: Trans-reflective Fetal EKG Monitor - Product Description 22
Table 30: LifeWave Hi-Tech Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 31: FetalConnect - Antepartum - Product Status 23
Table 32: FetalConnect - Antepartum - Product Description 23
Table 33: FetalConnect - Intrapartum - Product Status 24
Table 34: FetalConnect - Intrapartum - Product Description 24
Table 35: Lono Medical Systems, LLC. Pipeline Products & Ongoing Clinical Trials Overview 25
Table 36: Passive Fetal Heart Monitor - Product Status 25
Table 37: Passive Fetal Heart Monitor - Product Description 25
Table 38: MBDevice, LLC Pipeline Products & Ongoing Clinical Trials Overview 26
Table 39: MBDevice - Product Status 26
Table 40: MBDevice - Product Description 26
Table 41: MindChild Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 42: Meridian M100 - Product Status 27
Table 43: Meridian M100 - Product Description 27
Table 44: Meridian M110 Fetal Monitoring System - Product Status 28
Table 45: Meridian M110 Fetal Monitoring System - Product Description 28
Table 46: MindChild Meridian Fetal Heart Rate Monitor - Product Status 28
Table 47: MindChild Meridian Fetal Heart Rate Monitor - Product Description 29
Table 48: MindChild Medical Inc. - Ongoing Clinical Trials Overview 30
Table 49: MindChild Meridian Fetal Heart Rate Monitor - The Fetal EKG Study 31
Table 50: Monica Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
Table 51: Monica AN24 - Product Status 32
Table 52: Monica AN24 - Product Description 32
Table 53: Neoventa Medical AB Pipeline Products & Ongoing Clinical Trials Overview 33
Table 54: Integrated Fetal Monitor - Product Status 33
Table 55: Integrated Fetal Monitor - Product Description 33
Table 56: Perinatronics Medical systems Inc Pipeline Products & Ongoing Clinical Trials Overview 34
Table 57: Fetal Heart Rate Monitor - Product Status 34
Table 58: Fetal Heart Rate Monitor - Product Description 34
Table 59: Sattva MedTech Pipeline Products & Ongoing Clinical Trials Overview 35
Table 60: Sattva Fetal Lite - Product Status 35
Table 61: Sattva Fetal Lite - Product Description 35
Table 62: Tiny Kicks LLC Pipeline Products & Ongoing Clinical Trials Overview 36
Table 63: eMotion Fetal Activity Monitor - Product Status 36
Table 64: eMotion Fetal Activity Monitor - Product Description 36
Table 65: Tristan Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 37
Table 66: SQUID HTS fMCG Sensor - Product Status 37
Table 67: SQUID HTS fMCG Sensor - Product Description 37
Table 68: Transvaginal SQUID fMCG System - Product Status 38
Table 69: Transvaginal SQUID fMCG System - Product Description 38
Table 70: Two Dimensional Instruments, LLC Pipeline Products & Ongoing Clinical Trials Overview 39
Table 71: Cervical Dystocia Monitor - Product Status 39
Table 72: Cervical Dystocia Monitor - Product Description 39
Table 73: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 40
Table 74: Epidermal Electronic System - Maternal And Fetal Monitoring - Product Status 40
Table 75: Epidermal Electronic System - Maternal And Fetal Monitoring - Product Description 40
Table 76: Glossary 89

1.2 List of Figures
Figure 1: Fetal Monitors - Pipeline Products by Stage of Development 8
Figure 2: Fetal Monitors - Pipeline Products by Segment 9
Figure 3: Fetal Monitors - Pipeline Products by Territory 10
Figure 4: Fetal Monitors - Pipeline Products by Regulatory Path 11
Figure 5: Fetal Monitors - Pipeline Products by Estimated Approval Date 12
Figure 6: Fetal Monitors - Ongoing Clinical Trials 13

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Fetal Monitors - Medical Devices Pipeline Assessment, 2017

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027